Linde AG
frankfurt : LIN

December 05, 2011 02:46 ET

Linde to build hydrogen plant for chemical complex in Northeast China

MUNICH, GERMANY--(Marketwire - Dec 5, 2011) -

Linde AG / Linde to build hydrogen plant for chemical complex in Northeast China . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.

  * Joint on-site project with Evonik and Jishen
  * Initial investment valued at around EUR 42 million
  * Move strengthens Linde's position in North China

The technology group The Linde Group is set to build and operate a new hydrogen plant in the Jilin Chemical Industrial Park (JCIP) in Northeast China. The company will be investing around EUR 42 million in the first phase of this new project.

The hydrogen plant is expected to come on stream by the end of 2013, supplying several companies in the Jilin chemical complex with high-purity hydrogen. This park is home to the production facilities run by Evonik Industries and Jishen, a joint venture between the PetroChina Jilin Beifang Chemical Group and the Jilin Shenhua Group.

"The project further strengthens our leading position as a gases and engineering player in China," says Sanjiv Lamba, Member of the Executive Board of Linde AG responsible for Asia. "We are delighted to see more and more large-scale industrial developments in this dynamic region and - together with our partners - we are committed to supporting the development of these projects as we move forward."

The new hydrogen plant will use steam methane reforming (SMR) to produce 25,000 normal cubic metres of hydrogen per hour. It will be built by Linde's Engineering Division and operated by its Gases Division. In addition, Linde will set up a subsidiary, Linde Gases Jilin, to focus on further expanding the gas supply infrastructure in and around the JCIP chemical complex.

Chemical companies Jishen, Evonik Industries and Huntsman are investing around EUR 390 million in total to construct a chemical hub in Jilin that will produce high-pressure propylene oxide (HPPO). Evonik is building a 230 kta hydrogen peroxide plant to supply Jishen's 300 kta HPPO plant. Jishen will then supply the HPPO to Huntsman for its polyol plant.

The chemical hub will produce the building blocks for polyurethane plastics. These plastics are used to make a wide variety of products such as fibres, shoe soles, foam insulation, adhesives, mattresses and car seats.


The Linde Group is a world-leading gases and engineering company with around 50,000 employees working in more than 100 countries worldwide. In the 2010 financial year, it achieved sales of 12.868 billion euro. The strategy of The Linde Group is geared towards sustainable earnings-based growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. Linde is committed to technologies and products that unite the goals of customer value and sustainable development.

In Greater China, Linde has close to 4,000 employees working in around 50 subsidiaries and joint ventures, and 150 operational plants in major industrial hubs across the region. Linde Greater China is headquartered in Shanghai.

For more information, see The Linde Group online at http://www.linde.com

Press Release as PDF: http://hugin.info/125064/R/1568908/487631.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Linde AG via Thomson Reuters ONE

[HUG#1568908]

Contact Information

  • Further information:
    Media
    Uwe Wolfinger
    Telephone: +49.89.35757-1320

    Dr Thomas Hagn
    Telephone: +49.89.35757-1323

    Investor Relations
    Dr Dominik Heger
    Telephone: +49.89.35757-1334

    Lisa Tilmann
    Telephone: +49.89.35757-1328